Taiwan · Delayed Price · Currency is TWD TSH Biopharm Corporation Statistics
Total Valuation
TPEX:8432 has a market cap or net worth of TWD 2.36 billion. The enterprise value is 1.95 billion.
| Market Cap | 2.36B |
| Enterprise Value | 1.95B |
Important Dates
The next estimated earnings date is Wednesday, February 24, 2027.
| Earnings Date | Feb 24, 2027 |
| Ex-Dividend Date | Jun 12, 2026 |
Share Statistics
TPEX:8432 has 38.40 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 38.40M |
| Shares Outstanding | 38.40M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 2.15% |
| Owned by Institutions (%) | 0.72% |
| Float | 14.69M |
Valuation Ratios
The trailing PE ratio is 11.28.
| PE Ratio | 11.28 |
| Forward PE | n/a |
| PS Ratio | 1.54 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | 9.60 |
| P/OCF Ratio | 9.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.82, with an EV/FCF ratio of 7.93.
| EV / Earnings | 9.29 |
| EV / Sales | 1.27 |
| EV / EBITDA | 5.82 |
| EV / EBIT | 6.13 |
| EV / FCF | 7.93 |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.39 |
| Quick Ratio | 3.09 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.05 |
| Interest Coverage | 407.53 |
Financial Efficiency
Return on equity (ROE) is 16.11% and return on invested capital (ROIC) is 30.96%.
| Return on Equity (ROE) | 16.11% |
| Return on Assets (ROA) | 9.44% |
| Return on Invested Capital (ROIC) | 30.96% |
| Return on Capital Employed (ROCE) | 17.51% |
| Weighted Average Cost of Capital (WACC) | 5.62% |
| Revenue Per Employee | 20.15M |
| Profits Per Employee | 2.76M |
| Employee Count | 76 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 3.33 |
Taxes
In the past 12 months, TPEX:8432 has paid 54.09 million in taxes.
| Income Tax | 54.09M |
| Effective Tax Rate | 16.04% |
Stock Price Statistics
The stock price has increased by +12.87% in the last 52 weeks. The beta is 0.25, so TPEX:8432's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +12.87% |
| 50-Day Moving Average | 53.07 |
| 200-Day Moving Average | 52.17 |
| Relative Strength Index (RSI) | 71.30 |
| Average Volume (20 Days) | 136,284 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:8432 had revenue of TWD 1.53 billion and earned 209.85 million in profits. Earnings per share was 5.45.
| Revenue | 1.53B |
| Gross Profit | 807.28M |
| Operating Income | 318.28M |
| Pretax Income | 337.20M |
| Net Income | 209.85M |
| EBITDA | 332.17M |
| EBIT | 318.28M |
| Earnings Per Share (EPS) | 5.45 |
Balance Sheet
The company has 730.43 million in cash and 12.87 million in debt, with a net cash position of 717.56 million or 18.69 per share.
| Cash & Cash Equivalents | 730.43M |
| Total Debt | 12.87M |
| Net Cash | 717.56M |
| Net Cash Per Share | 18.69 |
| Equity (Book Value) | 1.81B |
| Book Value Per Share | 39.22 |
| Working Capital | 1.28B |
Cash Flow
In the last 12 months, operating cash flow was 247.50 million and capital expenditures -1.61 million, giving a free cash flow of 245.89 million.
| Operating Cash Flow | 247.50M |
| Capital Expenditures | -1.61M |
| Depreciation & Amortization | 13.89M |
| Net Borrowing | -12.72M |
| Free Cash Flow | 245.89M |
| FCF Per Share | 6.40 |
Margins
Gross margin is 52.72%, with operating and profit margins of 20.79% and 13.70%.
| Gross Margin | 52.72% |
| Operating Margin | 20.79% |
| Pretax Margin | 22.02% |
| Profit Margin | 13.70% |
| EBITDA Margin | 21.69% |
| EBIT Margin | 20.79% |
| FCF Margin | 16.06% |
Dividends & Yields
This stock pays an annual dividend of 2.61, which amounts to a dividend yield of 4.24%.
| Dividend Per Share | 2.61 |
| Dividend Yield | 4.24% |
| Dividend Growth (YoY) | 23.11% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 47.76% |
| FCF Payout Ratio | 40.76% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 4.16% |
| Earnings Yield | 8.86% |
| FCF Yield | 10.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |